Skip to content
Home/Companies/Pharma/Ardena
Ardena

Ardena

Pharma·Belgium·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Ardena?

Ardena is currently owned by GHO Capital through GHO Capital Fund II LP (2019 vintage), since 2020.

Hand-verified · updated 2026-07-07

GHO Capital
Investor
GHO Capital
GHO Capital Fund II LP · 2019 · Buyout

Key facts

HQBelgium
SectorPharma
StatusActive
Websiteardena.com

More from GHO Capital Fund II LP

Other portfolio companies in the same fund.

Validant
Validant
Active
Business ServicesUS· 2022
FairJourney Biologics
Exited 2024
BiotechPortugal· 2020
to
Sterling Pharma Solutions
Active
PharmaUK· 2019

More GHO Capital portfolio companies

From the same investor, across funds.

Avid Bioservices
Avid Bioservices
Active
BiotechUS· 2025
FotoFinder Systems
FotoFinder Systems
Active
MedTechGermany· 2025
Scientist.com
Scientist.com
Active
HealthTechUS· 2025
Alcami Corporation
Alcami Corporation
Active
PharmaUS· 2022
Sanner
Sanner
Active
MedTechGermany· 2022
Sapio Sciences
Sapio Sciences
Active
HealthTechUS· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Ardena

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ardena?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ardena.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue